2024-517010-15-01招募中1 期
Mesenchymal stromal cell therapy for rehabilitation after hip fracture.
Karolinska University Hospital1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年5月5日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 65 years 至 65+ years（65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Margareta Hedström
Scientific
Karolinska University Hospital
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Mesenchymal stem cell based therapy for the treatment of osteogenesis imperfectaOsteogenesis imperfecta (OI) is a rare genetic disorder with increased bone fragility of varying severity. In the majority of patients the disease is caused by mutations in collagen type I. Severe OI is characterized by osteopenia, frequent fractures, progressive deformity, short stature, loss of mobility, chronic pain and can lead to premature death. At present a cure does not exist.EUCTR2012-002553-38-ESItziar Astigarraga Aguirre
进行中（未招募）
不适用
Mesenchymal Stromal Cells (MSC) for the treatment of severe (grade II-IV) steroid-resistant Graft Versus Host Disease (GVHD): a phase I trial - MSC-GvHDGraft versus Host disease GvHD steroid resistantEUCTR2008-007869-23-ITAZIENDA OSPEDALIERA SAN GERARDO DI MONZA
Unknown
早期 1 期
Mesenchymal Stem Cell for Osteonecrosis of the Femoral HeadOsteochondritis of the Femoral HeadNCT00813267Jianming Tan15
已完成
不适用
Clinical trial of mesenchymal stem cell mobilization factor KOI2 in epidermolysis bullosa patientsepidermolysis bullosaJPRN-UMIN000029962Osaka University Hospital9
已完成
2 期
Adult mesenchymal stromal cells to regenerate the neonatal brain: the PASSIoN trial (Perinatal Arterial Stroke treated with Stromal cells IntraNasally)Neonatal StrokePAIS1000796310028920NL-OMON50715niversitair Medisch Centrum Utrecht10